In terms of the number of patients served and services provided, Krishna Medical Institution Ltd (KIMS), which was founded in 1973, is
Categories
Health Care
Apollo Hospitals Enterprise Limited Q4 FY23 Earnings Conference Call Insights
Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Management Update: [00:08:21] APOLLOHOSP said it has made significant progress
Venus Remedies Ltd Q4FY23 results out, revenue grows by over 10%
Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the
Jubilant Pharmova Q4FY23 Earnings Story
The three business components of Jubilant Pharmova Ltd, which include medicines, contract research and development services, and patented new therapies, make up
Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q4 FY23 Earnings Concall Transcript
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Q4 FY23 Earnings Concall dated May. 31, 2023 Corporate Participants: Mayank Vaswani -- Investor Relations Suneeta Reddy
Jubilant Pharmova Q4FY23; Reported Losses
Jubilant Pharmova Ltd.’s revenue in Q4FY23 rose 10% to ₹ 1,678 crores. Consolidated Loss After Tax came at ₹ 101 crores in
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 18, 2023. Corporate Participants: Bimal Lalitsingh Goculdas -- Chief Executive Officer Analysts: Abhishek Mehra -- TIL
Hester Biosciences Limited (HESTERBIO) Q4 FY23 Earnings Concall Transcript
Hester Biosciences Limited (NSE:HESTERBIO) Q4 FY23 Earnings Concall dated May. 17, 2023. Corporate Participants: Unidentified Speaker -- Analysts: Nirav Seksaria -- Living Root Capital --
AMI Organics Ltd (AMIORG) Q4 FY23 Earnings Concall Transcript
AMI Organics Ltd (NSE:AMIORG) Q4 FY23 Earnings Concall dated May. 15, 2023. Corporate Participants: Bhavin Shah -- Chief Financial Officer Nareshkumar Ramjibhai Patel -- Executive Chairman
Dr Lal PathLabs Ltd (LALPATHLAB) Q4 FY23 Earnings Concall Transcript
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q4 FY23 Earnings Concall dated May. 11, 2023. Corporate Participants: Hon. Brig. Dr. Arvind Lal -- Executive Chairman Om
Dr. Reddy’s Laboratories (DRREDDY) Q4 FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q4 FY23 Earnings Concall dated May. 10, 2023. Corporate Participants: Richa Periwal -- Investor Relations G V Prasad -- Co-Chairman and Managing
Vijaya Diagnostics Centre Ltd Q4FY23 results out, revenue grows by 4%
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Torrent Pharmaceuticals Ltd Q4FY23 revenue grows by 17%
Torrent Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹2,452 Crore, up from ₹ Crore year on year depicting a growth
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q4 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q4 FY23 Earnings Concall dated May. 30, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and Chief Financial
Supriya Lifescience Ltd (SUPRIYA) Q4 FY23 Earnings Concall Transcript
Supriya Lifescience Ltd (NSE:SUPRIYA) Q4 FY23 Earnings Concall dated May. 29, 2023. Corporate Participants: Irfan Raeen -- Investor Relations Satish Wagh --
Aurobindo Pharma Limited (AUROPHARMA) Q4 FY23 Earnings Concall Transcript
Aurobindo Pharma Limited (NSE:AUROPHARMA) Q4 FY23 Earnings Concall dated May. 28, 2023. Corporate Participants: Deepti Thakur -- Investor Relations & Corporate Communications
SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUNPHARMA) Q4 FY23 Earnings Concall Transcript
SUN PHARMACEUTICAL INDUSTRIES LIMITED (NSE : SUNPHARMA) Q4 FY23 Earnings Concall dated May. 26, 2023. Corporate Participants: Abhishek Sharma -- Head of
GMM Pfaudler Limited (GMMPFAUDLR) Q4 FY23 Earnings Concall Transcript
GMM Pfaudler Limited (NSE: GMMPFAUDLR) Q4 FY23 Earnings Concall dated May. 26, 2023 Corporate Participants: Priyanka Daga — Deputy General Manager Tarak Patel — Managing Director
Max India Limited (MAXIND) Q4 FY23 Earnings Concall Transcript
Max India Limited (NSE : MAXIND) Q4 FY23 Earnings Concall dated May. 26, 2023 Corporate Participants: Rajit Mehta -- Managing Director Ajay Agrawal -- Chief Financial
Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16%
Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting a growth
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) Q4 FY23 Earnings Concall Transcript
JB Chemicals & Pharmaceuticals Limited (NSE: JBCHEPHARM) Q4 FY23 Earnings Concall dated May. 25, 2023. Corporate Participants: Jason D'Souza -- Vice President,